Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4

The ALS4 team, Christopher Grunseich, MD, and Vivian G. Cheung, MD, with the National Institutes of Health recently published the following research paper, in which they summarize the clinical characteristics of ALS4. It's an excellent summary of the research and analysis of ALS4 to date.

You can read the full paper at the following location: Clinical and Molecular Aspects of Senataxin Mutations in Amyotrophic Lateral Sclerosis 4